Isoxazolylthioamides as potential immunosuppressants a combinatorial chemistry approach

Bioorganic and Medicinal Chemistry Letters

Volumn 8, Issue 16, 1998, Pages 2203-2208

  Albert, Rainer ^a   Knecht, Hellmut ^a   Andersen, Elsebeth ^a   Hungerford, Valerie ^a   Schreier, Max H ^a   Papageorgiou, Christos ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROOROTATE DEHYDROGENASE; DRUG METABOLITE; IMMUNOSUPPRESSIVE AGENT; ISOXAZOLYLTHIOAMIDE DERIVATIVE; LEFLUNOMIDE; THIOAMIDE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME INHIBITION; HUMAN; STRUCTURE ACTIVITY RELATION;

ANIMALS; ENZYME INHIBITORS; HUMANS; HYDROXYLAMINE; IMMUNOSUPPRESSIVE AGENTS; INDICATORS AND REAGENTS; ISOTHIOCYANATES; ISOXAZOLES; LYMPHOCYTE CULTURE TEST, MIXED; LYMPHOCYTES; MICE; MOLECULAR STRUCTURE; OXIDOREDUCTASES; OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS; PHENYLACETATES; RECOMBINANT PROTEINS; SPECTROMETRY, MASS, FAST ATOM BOMBARDMENT; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0032544172     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(98)00365-5     Document Type: Article

References (21)

1. 1. Silva, H.T. Jr.; Morris, R.E. Exp. Opin. Invest Drugs 1997, 6, 51.
2. 2. Williamson, R.A.; Yea, C.M.; Robson, P.A.; Curnock, A.P.; Gadher, S.; Hambleton, A.B.; Woodward, K.A.; Bruneau, J-M.; Hambleton, P.T.; Moss, D.; Thomson, T.A.; Spinella-Jaegle, S.; Morand, P.; Courtin, O.; Sautes, C.; Westwood, R.; Hercend, T.; Kuo, E.A.; Ruuth, E. J. Biol. Chem. 1997, 270, 22467.
3. 3. Xu, X.; Williams, J.W.; Gong, H.; Finnegan, A.; Chong, A.F. Biochem. Pharmacol. 1996, 52, 527.
4. 4. The unique example of a published crystal structure of a DHODH is that from Lactococcus lactis : Rowland, P.; Nielsen, F.S.; Jensen, K.F.; Larsen, S. Structure 1997, 5, 239. This information does not allow to make predictions concerning the structure of the human enzyme.
5. 5. Bardi, B.; Piazzesi, A.M.; Toniolo, C.; Jensen, O.E.; Omar, R.S.; Senning, A. Biopolymers 1998, 27, 747.
6. 6. Shutkowski, M.; Woellner, S., Fischer, G. Biochemistry 1995, 34, 13016.
7. Kessler, H.; Geyer, A.; Matter, H.; Koeck, M. Int. J. Peptide Protein Res. 1992, 40, 25.
8. Sherman, B.D.; Spatola, A.F. J. Am. Chem. Soc. 1990, 112, 433.
9. Seebach, D.; Ko, S.Y.; Kessler, H.; Koeck, M.; Reggelin, M.; Schmieder, P.; Walkinshaw, M.; Boesterli, J.; Bevec, D. Helv. Chim. Acta 1991, 74, 1953.
10. 7. Papageorgiou, C.; Zurini, M.; Weber, H.-P.; Borer, X. Bioorg. Chem. 1997, 25, 233.
11. 8. Kuo, E.A.; Hambleton, P.T.; Kay, D.P.; Evans, P.L.; Matharu, S.S.; Little, E.; McDowall, N.; Jones, C. B.; Hedgecock, C.J.R.; Yea, C.M.; Can, E.A.W.; Hairsine, P.W.; Ager, I.R.; Tully, R.W.; Williamson, R.A.; Westwood, R. J. Med. Chem. 1996, 39, 4608.
12. 9. Jung, G. Combinatorial peptide and nonpeptide libraries: A Handbook; Jung, G., Ed.; VCH: Weinheim, 1996.
13. 10. Panizzi, L.; Monti, E. Gazz. Chim. Ital. 1947, 77, 556.
14. 11. Goerdeler, J.; Laqua, A.; Lindner, C. Chem. Ber. 1974, 107, 3518.
15. 12. Borisevich, A.N.; Romanenko, E.A.; Lozinskii, M.O. and Samoilenko, L.S. Ukr. Khim. Zh (Russ. Ed.) 1986, 52(6), 641.
16. 13. Rapp, W. In Rapp Polymere; Price/Orderlist 1994/95; pp 1.
17. 14. Bodansky, M.; Bodansky A. The Practice of Peptide Synthesis; 2nd Ed.; Springer Verlag: Berlin Heidelberg, 1994, pp. 116-117.
18. t for 2b : 14.56 min.
19. 16. Davies, J.P.; Cain, G.A.; Pitts, W.J.; Magolda, R.L.; Copeland, R.A. Biochemistry 1996, 35, 1270.
20. 17. Meo, T. Immunological Methods; Lefkovits, L.; Pernis, B., Ed.; Academic Press : N.Y. 1970, pp. 227-239.
21. 18. A patent on thioleflunomide analogues as inhibitors of hyperproliferative cell growth was published during the preparation of this manuscript. The described compounds were obtained by solution chemistry : Tang, P.C. PCT Int. Appl. WO 9633179 A1 961024